Alerts will be sent to your verified email
Verify EmailBPLPHARMA
Bharat Parenterals
|
Lincoln Pharma
|
Anuh Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.41 % | 1.93 % | 0.0 |
Financials
|
|||
5 yr Average ROE
|
12.73 % | 15.94 % | 15.87 % |
5yr average Equity Multiplier
|
1.76 | 1.3 | 1.62 |
5yr Average Asset Turnover Ratio
|
0.86 | 0.84 | 1.35 |
5yr Avg Net Profit Margin
|
8.73 % | 14.61 % | 7.23 % |
Price to Book
|
3.17 | 1.59 | 2.94 |
P/E
|
0.0 | 12.99 | 20.25 |
5yr Avg Cash Conversion Cycle
|
122.06 Days | 24.49 Days | 42.81 Days |
Inventory Days
|
46.56 Days | 42.89 Days | 50.87 Days |
Days Receivable
|
179.99 Days | 90.22 Days | 111.12 Days |
Days Payable
|
95.97 Days | 111.35 Days | 117.6 Days |
5yr Average Interest Coverage Ratio
|
22.68 | 58.2 | 48.66 |
5yr Avg ROCE
|
16.02 % | 20.48 % | 21.17 % |
5yr Avg Operating Profit Margin
|
11.16 % | 18.48 % | 10.21 % |
5 yr average Debt to Equity
|
0.26 | 0.0 | 0.02 |
5yr CAGR Net Profit
|
-9.67 % | 12.65 % | 10.73 % |
5yr Average Return on Assets
|
8.0 % | 12.28 % | 9.84 % |
Shareholdings
|
|||
Promoter Holding
|
67.19 % | 49.78 % | 69.92 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-6.65 % | 5.7 % | -0.67 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Bharat Parenterals
|
Lincoln Pharma
|
Anuh Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|